Chlamydia trachomatis and its effects on host cells
Chlamydia trachomatis manipulates (PI)CALM to carry on
This study is looking at how the Chlamydia bacteria trick our body's cells to hide and cause infections, especially in women, with the goal of finding ways to prevent these infections and their serious health effects.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-10950429 on NIH RePORTER |
What this research studies
This research investigates how the bacterium Chlamydia trachomatis manipulates host cell processes to establish and maintain infections, particularly in women. It focuses on understanding the mechanisms that allow the bacteria to remain undetected by the immune system, which can lead to serious health issues like pelvic inflammatory disease and infertility. By studying the lifecycle of the bacteria within host cells, the research aims to identify potential strategies for preventing transmission and limiting infections. The approach includes examining the interactions between the bacteria and host cell components during infection.
Who could benefit from this research
Good fit: Ideal candidates for this research are women aged 15 to 19 who are at risk of Chlamydia trachomatis infections.
Not a fit: Patients who are not at risk for Chlamydia infections or who are already experiencing severe complications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for preventing Chlamydia infections and their associated complications in women.
How similar studies have performed: Previous research has shown success in understanding bacterial infections and their interactions with host cells, suggesting that this approach could yield valuable insights.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Rucks, Elizabeth Ann — University of Nebraska Medical Center
- Study coordinator: Rucks, Elizabeth Ann
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.